CLINICAL_TRIALS
trial_result
· 2017-04-20
Clinical Trial Update: Adjunctive Isradipine for the Treatment of Bipolar Depression [Phase 2]
Summary
Phase 2 trial evaluating adjunctive isradipine for bipolar depression was terminated; results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Bipolar Disorder | Phase 2 | Status: TERMINATED | Results posted: 2017-04-20